Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus

被引:9
|
作者
Murillo, O. [1 ]
Pachon, M. E. [1 ]
Euba, G. [1 ]
Verdaguer, R. [2 ]
Carreras, M. [3 ]
Cabellos, C. [1 ]
Cabo, J. [4 ]
Guidiol, F. [1 ]
Ariza, J. [1 ]
机构
[1] Hosp Univ Bellvitge, IDIBELL, Infect Dis Serv, Expt Infect Lab, Barcelona, Spain
[2] Hosp Univ Bellvitge, IDIBELL, Dept Microbiol, Barcelona, Spain
[3] Hosp Univ Bellvitge, IDIBELL, Dept Pathol, Barcelona, Spain
[4] Hosp Univ Bellvitge, IDIBELL, Dept Orthopaed Surg, Barcelona, Spain
关键词
staphylococci; intracellular bacteria; animal model; intracellular infection; device-related infections; SMALL COLONY VARIANTS; MODEL; LEVOFLOXACIN; METHICILLIN; PATHOGENESIS; NEUTROPHILS; RESISTANCE; INVIVO; AGENTS;
D O I
10.1093/jac/dkp326
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The presence of bacterial biofilm, tolerance to antibiotics and dysfunctional activity of phagocytic cells are all related to difficulties in eradicating foreign-body infections. We aimed to quantify the presence of intracellular Staphylococcus aureus and to study the extent to which the intracellular activity of antibiotics might determine their efficacy against an experimental rat tissue-cage model of foreign-body infection. Methods: Using this model, animals were treated for 7 days with 100 mg/kg/day levofloxacin or 200 mg/kg/12 h cloxacillin, or were left untreated. Antibiotic efficacy was evaluated by means of bacterial counts from tissue-cage fluid (TCF); these counts were derived separately in total, intracellular and extracellular bacteria. The presence of intracellular bacteria was checked by electron microscopy. Population analysis was performed with surviving bacteria recovered at the end of levofloxacin therapy. Results: Among a total number of bacteria (mean log cfu/mL +/- SD) from TCF of 6.86 +/- 0.6, we identified 6.38 +/- 0.8 intracellular bacteria and 5.57 +/- 0.5 extracellular bacteria. Levofloxacin was more efficient than cloxacillin (P<0.05) against both intracellular and extracellular bacteria. The killing activity of levofloxacin against the intracellular population was higher than against the extracellular bacteria (P=0.1). The frequency of levofloxacin-resistant mutants among surviving bacteria at the end of levofloxacin therapy was similar to that for the wild-type strain. Conclusions: Intracellular bacteria accounted for the largest proportion of the total inoculum in this model of foreign-body infection. The intracellular activity of an antibiotic seems to be an additional relevant factor in the antibiotic response to these infections.
引用
收藏
页码:1062 / 1066
页数:5
相关论文
共 50 条
  • [1] TREATMENT OF EXPERIMENTAL FOREIGN-BODY INFECTION CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    LUCET, JC
    HERRMANN, M
    ROHNER, P
    AUCKENTHALER, R
    WALDVOGEL, FA
    LEW, DP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) : 2312 - 2317
  • [2] Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection
    Trampuz, Andrej
    Murphy, Christopher K.
    Rothstein, David M.
    Widmer, Andreas F.
    Landmann, Regine
    Zimmerli, Werner
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2540 - 2545
  • [3] High Activity of Fosfomycin and Rifampin against MethicillinResistant Staphylococcus aureus Biofilm In Vitro and in an Experimental Foreign-Body Infection Model
    Mihailescu, Raluca
    Tafin, Ulrika Furustrand
    Corvec, Stephane
    Oliva, Alessandra
    Betrisey, Bertrand
    Borens, Oliver
    Trampuz, Andrej
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (05) : 2547 - 2553
  • [4] Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus
    Murillo, O.
    Domenech, A.
    Garcia, A.
    Tubau, F.
    Cabellos, C.
    Gudiol, F.
    Ariza, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) : 4011 - 4017
  • [5] EFFICACY OF SUBINHIBITORY CONCENTRATION OF PEFLOXACIN IN PREVENTING EXPERIMENTAL STAPHYLOCOCCUS-AUREUS FOREIGN-BODY INFECTION IN MICE
    CARSENTIETESSE, H
    ENTENZA, J
    DURANT, J
    PRADIER, C
    MONDAIN, V
    BERNARD, E
    DELLAMONICA, P
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1992, 18 (10) : 415 - 422
  • [6] Daptomycin combinations as alternative therapies in experimental foreign-body infection caused by meticillin-susceptible Staphylococcus aureus
    El Haj, Cristina
    Murillo, Oscar
    Ribera, Alba
    Vivas, Mireia
    Garcia-Somoza, Dolors
    Tubau, Fe
    Cabellos, Carmen
    Cabo, Javier
    Ariza, Javier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (02) : 189 - 195
  • [7] Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
    Murillo, O.
    Garrigos, C.
    Pachon, M. E.
    Euba, G.
    Verdaguer, R.
    Cabellos, C.
    Cabo, J.
    Gudiol, F.
    Ariza, J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4252 - 4257
  • [8] Linezolid Alone or Combined with Rifampin against Methicillin-Resistant Staphylococcus aureus in Experimental Foreign-Body Infection
    Baldoni, Daniela
    Haschke, Manuel
    Rajacic, Zarko
    Zimmerli, Werner
    Trampuz, Andrej
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1142 - 1148
  • [9] Activity of fixed direct electrical current in experimental Staphylococcus aureus foreign-body osteomyelitis
    Schmidt-Malan, Suzannah M.
    Brinkman, Cassandra L.
    Greenwood-Quaintance, Kerryl E.
    Karau, Melissa J.
    Mandrekar, Jayawant N.
    Patel, Robin
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (02) : 92 - 95
  • [10] Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus
    Garrigos, C.
    Murillo, O.
    Euba, G.
    Verdaguer, R.
    Tubau, F.
    Cabellos, C.
    Cabo, J.
    Ariza, J.
    JOURNAL OF INFECTION, 2011, 63 (03) : 229 - 235